Racial Differences in Malignant Left Ventricular Hypertrophy and Incidence of Heart Failure
Author(s) -
Alana Lewis,
Colby Ayers,
Elizabeth Selvin,
Ian J. Neeland,
Christie M. Ballantyne,
Vijay Nambi,
Ambarish Pandey,
Tiffany M. PowellWiley,
Mark H. Drazner,
Mercedes R. Carnethon,
Jarett D. Berry,
Stephen L. Seliger,
Christopher R. deFilippi,
James A. de Lemos
Publication year - 2020
Publication title -
circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.795
H-Index - 607
eISSN - 1524-4539
pISSN - 0009-7322
DOI - 10.1161/circulationaha.119.043628
Subject(s) - medicine , left ventricular hypertrophy , cardiology , heart failure , incidence (geometry) , cardiac hypertrophy , myocardial hypertrophy , muscle hypertrophy , blood pressure , physics , optics
A malignant subphenotype of left ventricular hypertrophy (LVH) has been described, in which minimal elevations in cardiac biomarkers identify individuals with LVH at high risk for developing heart failure (HF). We tested the hypothesis that a higher prevalence of malignant LVH among blacks may contribute to racial disparities in HF risk.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom